SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-040851
Filing Date
2020-03-31
Accepted
2020-03-31 08:25:56
Documents
2
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm206481d3_6k.htm 6-K 11709
2 EXHIBIT 99.1 tm206481d3_ex99-1.htm EX-99.1 93313
  Complete submission text file 0001104659-20-040851.txt   106220
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 20759709
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences